GlassScriptPhysician profile
Elizbeth Lofton
NPI 1700623790
$8,180.75
in general payments reported to CMS, 2019-2025
22 companies · $6,872 in 2025
The $6,872 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,309 · 2025: $6,872.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,483 · Travel and Lodging: $2,655 · Education: $42.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,482.97 |
| Travel and Lodging | $2,654.83 |
| Education | $42.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $3,937.73 | 2024-2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $781.55 | 2024-2025 | Airsupra, Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $763.53 | 2025 | Nucala, Trelegy Ellipta |
| Mallinckrodt Hospital Products INC. | $446.55 | 2024-2025 | Acthar |
| Genzyme Corporation | $401.12 | 2024-2025 | |
| Jazz Pharmaceuticals INC. | $399.56 | 2024-2025 | |
| Verona Pharma, INC. | $362.57 | 2025 | Ohtuvayre |
| Boehringer Ingelheim Pharmaceuticals, INC. | $248.37 | 2024-2025 | Ofev, Jascayd |
| Takeda Pharmaceuticals U.S.A., INC. | $147.59 | 2024-2025 | Glassia |
| Regeneron Healthcare Solutions, INC. | $121.29 | 2024-2025 | Dupixent |
| Insmed, INC. | $115.67 | 2025 | Brinsupri, Arikayce |
| Ani Pharmaceuticals, INC. | $98.19 | 2024-2025 | Purified Cortrophin Gel |
| United Therapeutics Corporation | $70.20 | 2025 | Tyvaso |
| Merck Sharp & Dohme LLC | $64.26 | 2025 | Zerbaxa |
| Avadel Cns Pharmaceuticals, LLC | $48.73 | 2025 | Lumryz |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $48.14 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Ambu INC. | $34.09 | 2025 | |
| Axsome Therapeutics, INC. | $26.25 | 2025 | Sunosi |
| Abbvie INC. | $20.25 | 2025 | |
| Mylan Specialty L.P. | $16.53 | 2024 | Yupelri |
| Amgen INC. | $14.75 | 2025 | Tezspire |
| Viatris Specialty LLC | $13.83 | 2025 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizbeth Lofton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.